Lee Kevin C, Chuang Sung-Kiang, Philipone Elizabeth M, Peters Scott M
Division of Oral and Maxillofacial Surgery, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA.
Department of Oral and Maxillofacial Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Head Neck Pathol. 2019 Sep;13(3):378-385. doi: 10.1007/s12105-018-0978-3. Epub 2018 Oct 24.
Head and neck angiosarcomas (HN-AS) are rare malignancies with a poor prognosis relative to other soft tissue sarcomas. To date, the HN-AS literature has been limited to short reports and single-institution experiences. This study evaluated patients registered with the Surveillance, Epidemiology, and End Results (SEER) program who had been diagnosed with a primary HN-AS. Predictors were drawn from demographic and baseline tumor characteristics. Outcomes were survival months and cause of death. Kaplan-Meier analyses were used to estimate overall (OS) and disease-specific survival (DSS) rates. Cox proportional hazards regression models were used for multivariate analyses. A total of 1250 patients (mean age 73.3 years) were identified, and nearly all lesions (93.5%) were cutaneous. Two- and 5-year OS rates were 47.3% (95% CI 44.3-50.3) and 26.5% (95% CI 23.7-29.3), while 2- and 5-year DSS rates were 66.6% (95% CI 63.6-69.6) and 48.3% (95% CI 44.5-52.1). In the univariate analyses, age, race, tumor grade, tumor size, AJCC stage, SEER historic stage, and surgery were significant predictors of both OS and DSS. Multivariate regression revealed that independent predictors of poor OS and DSS were older age [OS: HR 1.04 (95% CI 1.02-1.05), p < 0.01; DSS: HR 1.03 (95% CI 1.01-1.05), p < 0.01], increased tumor size [OS: HR 1.01 (95% CI 1.01-1.01), p < 0.01; DSS: HR 1.01 (95% CI 1.01-1.02), p < 0.01], and distant disease [OS: HR 2.97 (95% CI 1.65-5.34), p < 0.01; DSS: HR 4.99 (95% CI 2.50-9.98), p < 0.01]. Age, tumor size, and disease extent were determinants of HN-AS survival. When all other factors were controlled, lower histologic grade and surgery did not improve the risk of death.
头颈部血管肉瘤(HN-AS)是一种罕见的恶性肿瘤,与其他软组织肉瘤相比预后较差。迄今为止,关于HN-AS的文献仅限于简短报告和单机构经验。本研究评估了监测、流行病学和最终结果(SEER)计划登记的诊断为原发性HN-AS的患者。预测因素来自人口统计学和基线肿瘤特征。结局指标为生存月数和死亡原因。采用Kaplan-Meier分析估计总生存率(OS)和疾病特异性生存率(DSS)。采用Cox比例风险回归模型进行多变量分析。共确定了1250例患者(平均年龄73.3岁),几乎所有病变(93.5%)为皮肤病变。2年和5年OS率分别为47.3%(95%CI 44.3-50.3)和26.5%(95%CI 23.7-29.3),而2年和5年DSS率分别为66.6%(95%CI 63.6-69.6)和48.3%(95%CI 44.5-52.1)。在单变量分析中,年龄、种族、肿瘤分级、肿瘤大小、美国癌症联合委员会(AJCC)分期、SEER历史分期和手术是OS和DSS的重要预测因素。多变量回归显示,OS和DSS较差的独立预测因素为年龄较大[OS:风险比(HR)1.04(95%CI 1.02-1.05),p<0.01;DSS:HR 1.03(95%CI 1.01-1.05),p<0.01]、肿瘤大小增加[OS:HR 1.01(95%CI 1.01-1.01),p<0.01;DSS:HR 1.01(95%CI 1.01-1.02),p<0.01]和远处转移[OS:HR 2.97(95%CI 1.65-5.34),p<0.01;DSS:HR 4.99(95%CI 2.50-9.98),p<0.01]。年龄、肿瘤大小和疾病范围是HN-AS生存的决定因素。当控制所有其他因素时,较低的组织学分级和手术并不能降低死亡风险。